Alvotech (ALVO) Change in Inventory (2021 - 2026)
Alvotech's (ALVO) quarterly Change in Inventory came in at -$11.0 million in Q1 2026, up 25.9% YoY from -$8.8 million in Q1 2025, and down 158.81% on a QoQ basis from -$4.3 million in Q4 2025.
Alvotech (ALVO) Change in Inventory (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has 6 years of Change in Inventory data on file, last reported at -$11.0 million in Q1 2026.
- Quarterly Change in Inventory rose 25.9% year-over-year to -$11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$86.3 million (up 13.26% YoY) and the FY2025 annual result came in at -$90.1 million, down 80.36% from the prior year.
- Change in Inventory slipped to -$11.0 million in Q1 2026, from -$4.3 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of -$2.8 million in Q2 2024 to a low of -$53.0 million in Q3 2025.
- A 5-year average of -$17.7 million and a median of -$11.3 million in 2023 frame the typical range for Change in Inventory.
- The widest YoY moves for Change in Inventory: up 91.48% in 2025, down 546.1% in 2025.
- Tracing ALVO's Change in Inventory over 5 years: stood at -$32.4 million in 2022, then soared by 65.12% to -$11.3 million in 2023, then slumped by 342.08% to -$50.0 million in 2024, then jumped by 91.48% to -$4.3 million in 2025, then sank by 158.81% to -$11.0 million in 2026.
- The last three Change in Inventory figures came in at -$11.0 million (Q1 2026), -$4.3 million (Q4 2025), and -$53.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alvotech | 1.23 Bn | 1.23 Bn | 5.09 Mn | -11.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.02 Mn |
| Mar 31, 2026 | -11.02 Mn |
| Dec 31, 2025 | -4.26 Mn |
| Dec 31, 2025 | -4.26 Mn |
| Sep 30, 2025 | -53.03 Mn |
| Sep 30, 2025 | -53.03 Mn |
| Jun 30, 2025 | -17.97 Mn |
| Jun 30, 2025 | -17.97 Mn |
| Mar 31, 2025 | -14.87 Mn |
| Mar 31, 2025 | -14.87 Mn |
| Dec 31, 2024 | -49.97 Mn |
| Dec 31, 2024 | -49.97 Mn |
| Sep 30, 2024 | -31.85 Mn |
| Sep 30, 2024 | -31.85 Mn |
| Jun 30, 2024 | -2.78 Mn |
| Jun 30, 2024 | -2.78 Mn |
| Mar 31, 2024 | -12.42 Mn |
| Mar 31, 2024 | -12.42 Mn |
| Dec 31, 2023 | -11.30 Mn |
| Dec 31, 2023 | -11.30 Mn |